NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/22/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Current location
Mark description
The mark consists of the following: a black, stylized letter "h" and green letters "VIVO" in standard characters. The white background in the drawing represents background areas, and the color white is not a part of the mark.
Holders
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
[ Pharmaceutical and medical compositions for human and/or veterinary use, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; diagnostic preparations and substances for medical purposes; medical diagnostic reagents; antiserums for diagnostic purposes for medical purposes; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical reagents for medical, pharmaceutical and veterinary purposes; viruses for the treatment of humans and/or animals, namely, viruses for use as an ingredient in vaccines for preventing and treatment of influenza or HRV or RSV; diagnostic preparations for medical purposes; in-vitro diagnostic reagents for medical purposes; in-vivo reagents for diagnostic medical purposes ]
Class 35
Business investigation and research services relating to cost and business efficiency, all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; systemization and compilation of medical information into computer databases; providing statistical information for business purposes, all of said information relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; registration services for diagnostic testing, namely, services consisting of the registration, collection, transcription, compilation and systemization of written communications and data with respect to diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management services, including information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical, hospital, insurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medical, health or clinical care; collation and provision of business information regarding results from diagnostic testing in relation to medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medical, hospital, insurance or billing records
Class 42
Medical research services; conducting clinical trials for others; medical research laboratory services; scientific analysis and research services, namely scientific research; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; medical and health care research services in the field of clinical testing services, physician testing services for assisting pharmacists, pharmacy testing services, medical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold; research services in the field of medical diagnostics; medical laboratory services for the analysis of samples taken from patients for research purposes
History of USPTO decisions and trademark events.
47 publications found
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/22/2026
REGISTERED - PARTIAL SEC 71 ACCEPTED
05/22/2026
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/18/2026
TEAS SECTION 71 RECEIVED
01/20/2026
INTERNATIONAL REGISTRATION RENEWED
05/01/2025
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/30/2024
FINAL DECISION TRANSACTION PROCESSED BY IB
11/30/2019
FINAL DISPOSITION NOTICE SENT TO IB
11/06/2019
FINAL DISPOSITION PROCESSED
11/06/2019
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/30/2019
REGISTERED-PRINCIPAL REGISTER
07/30/2019
NOTIFICATION PROCESSED BY IB
05/31/2019
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2019
PUBLISHED FOR OPPOSITION
05/14/2019
NEW REPRESENTATIVE AT IB RECEIVED
05/09/2019
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/24/2019
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2019
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/24/2019
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2019
TEAS/EMAIL CORRESPONDENCE ENTERED
03/21/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/21/2019
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/21/2019
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/02/2018
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/01/2018
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/20/2017
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/19/2017
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/20/2017
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/04/2017
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/04/2017
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/13/2016
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/07/2016
ASSIGNED TO LIE
03/22/2016
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/22/2015
LETTER OF SUSPENSION E-MAILED
09/22/2015
SUSPENSION LETTER WRITTEN
09/22/2015
REFUSAL PROCESSED BY IB
09/18/2015
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2015
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2015
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/17/2015
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/27/2015
REFUSAL PROCESSED BY MPU
08/27/2015
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2015
NON-FINAL ACTION WRITTEN
08/26/2015
ASSIGNED TO EXAMINER
08/13/2015
APPLICATION FILING RECEIPT MAILED
08/11/2015
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2015
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/30/2015
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.